Response Genetics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.10.13	ZLCS Effects Reverse Split, STEM Growing Up, Rockwell Rocks, What's Moving PSTI? (RTTNews)
27.08.13	ACUR Crushed, RGDX Loosens Purse Strings, QRxPharma's Trading Halted (RTTNews)
26.08.13	Response Genetics Buys Main Assets Of Pathwork Diagnostics (RTTNews)
13.08.13	GALT Vaults, BIOD, CCXI, ESPR Await Q3 Catalysts, Watch Out For OSIR (RTTNews)
17.07.13	Response Genetics, Taiho Renew Deal To Provide Molecular Analyses For Cancer (RTTNews)
30.05.12	Response Genetics Announces Presentation of Lung Cancer Study Results at 2012 American Society of Clinical Oncology Annual Meeting (Businesswire)
10.05.12	Response Genetics, Inc. Announces First Quarter Financial Results (Businesswire)
04.05.12	Response Genetics, Inc. to Release First Quarter Financial Results and Host Conference Call on May 10, 2012 (Businesswire)
27.03.12	Response Genetics, Inc. Announces Year-End and Fourth Quarter Financial Results (Businesswire)
26.03.12	Response Genetics, Inc. Announces Appointment of Stephanie Astrow, Ph.D., as Vice President, Research and Development (Businesswire)
21.03.12	Response Genetics, Inc. to Release Fourth Quarter and Full-Year 2011 Financial Results and Host Conference Call on March 27, 2012 (Businesswire)
21.02.12	Response Genetics Regains NASDAQ Compliance (Businesswire)
06.02.12	Response Genetics to Present at the 22nd Annual UBS Global Healthcare Services Conference (Businesswire)
02.02.12	Response Genetics Raises More Than $7.8 Million in Financing (Businesswire)
22.12.11	Response Genetics Names Thomas A. Bologna Chairman and CEO (Businesswire)
21.12.11	Response Genetics, Inc. to Offer FDA-Approved ALK Test for metastatic NSCLC (Businesswire)
10.11.11	Response Genetics, Inc. Reports Third Quarter Financial Results and Operational Update (Businesswire)
10.11.11	hhgregg to Offer NOOK Tablet™, NOOK Simple Touch Reader™ and NOOK Color™ by Barnes & Noble (Businesswire)
07.11.11	Zuoan Fashion Limited Announces Participation in the Cowen China Opportunity Conference (Businesswire)
07.11.11	Riverbed Technology to Present at Upcoming Events with the Financial Community (Businesswire)
07.11.11	Gilead Sciences and Cardiovascular Research Foundation Initiate Phase 3 Clinical Trial with Ranolazine in Patients Who Have Undergone PCI with a History of Prior Chronic Angina (Businesswire)
07.11.11	Response Genetics, Inc. to Release Third Quarter 2011 Financial Results (Businesswire)
12.05.11	Janus to Offer Long/Short Hedge Fund with Appointment of Alternatives Manager (Businesswire)
15.07.10	Response Genetics Inc. Sets Date for 2010 Annual Meeting of Stockholders, Announces Board Slate (Businesswire)
30.06.10	Response Genetics Launches EML4-ALK Genetic Test in Lung Cancer (Businesswire)
05.05.10	Saba to Kick Off Chicago Regional User Group Conference (Businesswire)
19.01.10	Response Genetics Announces Appointment of Dr. Edith P. Mitchell to Board of Directors (Businesswire)
26.03.09	Response Genetics, Inc. Reports Full Year 2008 and Fourth Quarter Financial Results and Provides ResponseDX™ Sales Update (Businesswire)
03.02.09	Response Genetics Signs Agreement With Roche Diagnostics to Support Cancer Test Development (Businesswire)
07.11.08	Response Genetics, Inc. Reports Third Quarter and Year-to-Date 2008 Financial Results (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Response Genetics IncShs

Aktien Top/Flop

Meistgelesene Nachrichten